According to the latest report
published by Credence Research, Inc. “Intracranial
Stents Market By Type Of Product (Self-Expanding Intracranial
Stents, Balloon Expanding Stents, Stent-Assisted Coil Embolization), By Disease
(Brain Aneurysms, Intracranial Stenosis) - Growth, Future Prospects, And
Competitive Analysis, 2018 - 2026,” the global Intracranial Stents
market was valued at USD 293.7 Mn in 2017, and is expected to reach USD 691.2
Mn by 2026, expanding at a CAGR of 9.9% from 2018 to 2026.
Browse the full report Intracranial
Stents Market - Growth, Future Prospects and Competitive Analysis,
2018-2026 report at https://www.credenceresearch.com/report/intracranial-stents-market
Market Insights
Stroke is the leading cause of
disability in adults which usually occurs due to narrowing of major
intracranial arteries followed by deposition of atherosclerotic plaque.
Prevalence of intracranial atherosclerotic disease (ICAD) is highly prevalent
in Asian population. Initially ICAD is treated with antithrombotics,
antihypertensives, statins, and risk factor controls. However, in emergency
cases or other complications intracranial stenting is preferred but comparatively
intracranial stenting has low adoption rate mainly due to negative impact of
SAMMPRIS trial. The other growth restraining factors of intracranial stenting
market are developing healthcare infrastructure in many Asian countries, high
costs of neurological surgeries, requirement of highly trained & skilled
practitioner, and minimum product penetration. The trials such as SAMMPRIS and
VISSIT concluded that the aggressive drug therapy was superior to angioplasty
and stenting. These results have highly influenced the key opinion leaders to
support endovascular treatment for ICAD leading to minimize the target
indications for Stryker’s Wingspan stent which is the only USFDA approved
product. However in early 2018, results of the WEAVE trial were published which
was not a randomized clinical trial, it was identified that fewer adverse
effects in patients were treated on-label with the Wingspan stent system,
concluding that intracranial stenting can be used for a particular set of
high-risk ICAD patients.
The type of intracranial stents
present in the market are self-expanding intracranial stents, balloon expanding
stents, and stent-assisted coil embolization. In 2017, stent-assisted coil
embolization accounted for the largest market share due to key driving factors such
as being one of the initially approved stents, evolved noticeably over the
years, and rising prevalence of intracranial stenosis. On the basis of diseases
intracranial stents market is segmented as intracranial stenosis and brain
aneurysm out of which intracranial stenosis was observed as the largest market.
The key factors responsible for growth of intracranial stenosis treatment
market due to high prevalence of intracranial stenosis, technological
development in the field of intracranial stenosis diagnosis, and increasing
awareness related to treatment of intracranial stenosis.
North America was identified as the
largest market throughout the forecast period from 2018 to 2026 due to key
factors such as rising prevalence of intracranial stenosis & brain
aneurysm, developed healthcare infrastructure along with high public awareness
related to early diagnosis, and high penetration of intracranial stents along
with efficient skilled practitioner. According to the American Heart
Association, atherosclerotic stenosis was identified as the major cause of
around 700,000 strokes occurring yearly in the United States. Thus, overall
North America is expected to maintain its dominance throughout the forecast
period.
Market
Competition Assessment:
The intracranial stents market is
growing significantly and major companies present in this market are focusing
on the development of safe & efficient intracranial stents. The major
companies in this market are Boston Scientific Corporation, Johnson &
Johnson Services, Inc., Stryker Corporation, Penumbra, Inc., Medtronic plc,
Terumo Corporation, and Cook Medical among others.
Key Market
Movements:
- Increasing demand for minimally invasive
surgical treatment is expected to assist the intracranial stenosis
- Incessant development in the technology
of intracranial stents will drive the demand for safe & efficient
stents
- Negative results of SAMMPRIS trial has
created a negative impact of intracranial stents in the market
- Ongoing research and development in the
field of intracranial stents market is expected to assist the overall
market growth in the near future
Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59567
Table of Content
Chapter 1.
Preface
1.1. Report Scope and Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
1.1. Report Scope and Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2.
Executive Summary
2.1. Global Intracranial Stents Market Portraiture
2.2. Global Intracranial Stents Market, by Type of Product, 2017 (US$ Mn)
2.3. Global Intracranial Stents Market, by Disease, 2017 (US$ Mn
2.4. Global Intracranial Stents Market, by Geography, 2017 Vs 2026 (Value %)
2.1. Global Intracranial Stents Market Portraiture
2.2. Global Intracranial Stents Market, by Type of Product, 2017 (US$ Mn)
2.3. Global Intracranial Stents Market, by Disease, 2017 (US$ Mn
2.4. Global Intracranial Stents Market, by Geography, 2017 Vs 2026 (Value %)
Chapter 3. Global
Intracranial Stents Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.2.1. Increasing prevalence of intracranial stenosis and brain aneurysms
3.2.2. Technological development in the intracranial stents
3.3. Challenges
3.3.1. Stringent regulatory policies have increased the rate of product recall
3.4. Opportunities
3.4.1. Rising awareness related to neurological diseases treatment and demand for minimally invasive surgeries
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2017
3.1. Market Overview
3.2. Drivers
3.2.1. Increasing prevalence of intracranial stenosis and brain aneurysms
3.2.2. Technological development in the intracranial stents
3.3. Challenges
3.3.1. Stringent regulatory policies have increased the rate of product recall
3.4. Opportunities
3.4.1. Rising awareness related to neurological diseases treatment and demand for minimally invasive surgeries
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2017
Chapter 4. Global
Intracranial Stents Market, by Type of Product, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Self-Expanding Intracranial Stents
4.3. Balloon Expanding Stents
4.4. Stent-assisted Coil Embolization
4.1. Overview
4.2. Self-Expanding Intracranial Stents
4.3. Balloon Expanding Stents
4.4. Stent-assisted Coil Embolization
Chapter 5. Global
Intracranial Stents Market, by Disease, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Brain Aneurysms
5.3. Intracranial Stenosis
5.1. Overview
5.2. Brain Aneurysms
5.3. Intracranial Stenosis
Do Inquiry before
buying research report: https://www.credenceresearch.com/inquiry-before-buying/59567
About Us
Credence
Research is a worldwide market research and counseling firm that serves driving
organizations, governments, non legislative associations, and not-for-benefits.
We offer our customers some assistance with making enduring enhancements to
their execution and understand their most imperative objectives. Over almost a
century, we've manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
Toll-Free (US/CANADA) Ph.: +1-800-361-8290
Website: http://www.credenceresearch.com
No comments:
Post a Comment